Primary multiple synchronous tumors: soft tissue sarcoma of the retroperitoneal space and metastatic prostate cancer

At the present time primary-multiple malignancies are of interest in connection with the frequency of prevalence, which remains at the rather high level and continues to grow up, therefore increasing the relevance of this pathology in clinical oncology and everyday practice. With the exception of th...

Full description

Saved in:
Bibliographic Details
Main Authors: O. A. Mailyan, K. Yu. Kanukoev, P. G. Berezin, K. M. Nyushko, V. A. Gorbach
Format: Article
Language:Russian
Published: QUASAR, LLC 2020-06-01
Series:Исследования и практика в медицине
Subjects:
Online Access:https://www.rpmj.ru/rpmj/article/view/550
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832568647896268800
author O. A. Mailyan
K. Yu. Kanukoev
P. G. Berezin
K. M. Nyushko
V. A. Gorbach
author_facet O. A. Mailyan
K. Yu. Kanukoev
P. G. Berezin
K. M. Nyushko
V. A. Gorbach
author_sort O. A. Mailyan
collection DOAJ
description At the present time primary-multiple malignancies are of interest in connection with the frequency of prevalence, which remains at the rather high level and continues to grow up, therefore increasing the relevance of this pathology in clinical oncology and everyday practice. With the exception of the treatment of primary multiple malignancies requiring a multimodal approach, as well as in the case of the use of complex treatment in conjunction with chemotherapists and radiotherapy specialists. In the past three decades, the development of screening tests that prevent and detect some cancers at an early, more treatable stage, and treatment advances have increased the 5‑year relative survival rate for all cancers to 66%. In addition to concerns about cancer recurrence, survivors also worry about their risk of developing a new cancer. Prostate cancer is a leader in terms of morbidity and mortality in the world, just as often are found in combination with other malignant tumors. However, given the high detectability of prostate cancer, primary patients are currently receiving radical treatment, and if metastatic prostate cancer is detected, they are receiving drug treatment, which improves the survival and quality of life of patients. Soft tissue sarcomas are rare malignant tumors that develop in the connective tissues and remain poorly understood due to the fact that they make up less than 1% of all malignant diseases. One of the main methods for treating soft tissue sarcomas is the surgical method. Soft tissue sarcomas are difficult to treat and therefore it is imperative that surgeons and other specialists have experience in treating this disease. Studies show that patients with this pathology show better results if they receive treatment in specialized cancer centers that have experience in treating soft tissue sarcoma. This article demonstrates the clinical case of surgical treatment of a patient with primary multiple retroperitoneal tumors and metastatic prostate cancer.
format Article
id doaj-art-7eef169d710447819cca81f7dc13be83
institution Kabale University
issn 2410-1893
language Russian
publishDate 2020-06-01
publisher QUASAR, LLC
record_format Article
series Исследования и практика в медицине
spelling doaj-art-7eef169d710447819cca81f7dc13be832025-02-03T00:57:39ZrusQUASAR, LLCИсследования и практика в медицине2410-18932020-06-017217117810.17709/2409-2231-2020-7-2-16331Primary multiple synchronous tumors: soft tissue sarcoma of the retroperitoneal space and metastatic prostate cancerO. A. Mailyan0K. Yu. Kanukoev1P. G. Berezin2K. M. Nyushko3V. A. Gorbach4National Medical Research Radiological CentreNational Medical Research Radiological CentreTambov Regional Oncology Clinical DispensaryNational Medical Research Radiological CentreScientific Research Geotechnological Centre Far Eastern Branch of Russian Academy of SciencesAt the present time primary-multiple malignancies are of interest in connection with the frequency of prevalence, which remains at the rather high level and continues to grow up, therefore increasing the relevance of this pathology in clinical oncology and everyday practice. With the exception of the treatment of primary multiple malignancies requiring a multimodal approach, as well as in the case of the use of complex treatment in conjunction with chemotherapists and radiotherapy specialists. In the past three decades, the development of screening tests that prevent and detect some cancers at an early, more treatable stage, and treatment advances have increased the 5‑year relative survival rate for all cancers to 66%. In addition to concerns about cancer recurrence, survivors also worry about their risk of developing a new cancer. Prostate cancer is a leader in terms of morbidity and mortality in the world, just as often are found in combination with other malignant tumors. However, given the high detectability of prostate cancer, primary patients are currently receiving radical treatment, and if metastatic prostate cancer is detected, they are receiving drug treatment, which improves the survival and quality of life of patients. Soft tissue sarcomas are rare malignant tumors that develop in the connective tissues and remain poorly understood due to the fact that they make up less than 1% of all malignant diseases. One of the main methods for treating soft tissue sarcomas is the surgical method. Soft tissue sarcomas are difficult to treat and therefore it is imperative that surgeons and other specialists have experience in treating this disease. Studies show that patients with this pathology show better results if they receive treatment in specialized cancer centers that have experience in treating soft tissue sarcoma. This article demonstrates the clinical case of surgical treatment of a patient with primary multiple retroperitoneal tumors and metastatic prostate cancer.https://www.rpmj.ru/rpmj/article/view/550primary multiple synchronous tumorsmetastatic prostate cancersoft tissue sarcoma of the retroperitoneal spacededifferentiated retroperitoneal liposarcomanephroadrenalectomycombination treatment
spellingShingle O. A. Mailyan
K. Yu. Kanukoev
P. G. Berezin
K. M. Nyushko
V. A. Gorbach
Primary multiple synchronous tumors: soft tissue sarcoma of the retroperitoneal space and metastatic prostate cancer
Исследования и практика в медицине
primary multiple synchronous tumors
metastatic prostate cancer
soft tissue sarcoma of the retroperitoneal space
dedifferentiated retroperitoneal liposarcoma
nephroadrenalectomy
combination treatment
title Primary multiple synchronous tumors: soft tissue sarcoma of the retroperitoneal space and metastatic prostate cancer
title_full Primary multiple synchronous tumors: soft tissue sarcoma of the retroperitoneal space and metastatic prostate cancer
title_fullStr Primary multiple synchronous tumors: soft tissue sarcoma of the retroperitoneal space and metastatic prostate cancer
title_full_unstemmed Primary multiple synchronous tumors: soft tissue sarcoma of the retroperitoneal space and metastatic prostate cancer
title_short Primary multiple synchronous tumors: soft tissue sarcoma of the retroperitoneal space and metastatic prostate cancer
title_sort primary multiple synchronous tumors soft tissue sarcoma of the retroperitoneal space and metastatic prostate cancer
topic primary multiple synchronous tumors
metastatic prostate cancer
soft tissue sarcoma of the retroperitoneal space
dedifferentiated retroperitoneal liposarcoma
nephroadrenalectomy
combination treatment
url https://www.rpmj.ru/rpmj/article/view/550
work_keys_str_mv AT oamailyan primarymultiplesynchronoustumorssofttissuesarcomaoftheretroperitonealspaceandmetastaticprostatecancer
AT kyukanukoev primarymultiplesynchronoustumorssofttissuesarcomaoftheretroperitonealspaceandmetastaticprostatecancer
AT pgberezin primarymultiplesynchronoustumorssofttissuesarcomaoftheretroperitonealspaceandmetastaticprostatecancer
AT kmnyushko primarymultiplesynchronoustumorssofttissuesarcomaoftheretroperitonealspaceandmetastaticprostatecancer
AT vagorbach primarymultiplesynchronoustumorssofttissuesarcomaoftheretroperitonealspaceandmetastaticprostatecancer